Trellus Health PLC Equity Research & Stock Reports

Equity Research, Broker Reports, and media content on Trellus Health PLC

Access the latest forecasts, broker valuations, multiples, and video content from the city about Trellus Health PLC
See live updates from analysts, company announcements, and other news in a personalised/single dashboard

23 Apr 24

FY23 results – pivotal period ahead

With the signing of a large-scale pilot contract with United Healthcare in February, Trellus is entering a key period in its development. Patient enrolment is underway and both management and the partner are reported to be encouraged by early adoption trends. It is well capitalised, with $12.2m in cash as at the end of Dec-23 and has completed development of an enterprise technology platform capable of being used at scale. The cash runway has been extended to mid-2025, providing management with

Companies: Trellus Health PLC

Singer Capital Markets

23 May 23

FY22 prelims – cash ahead, pivotal year in store

2022 was an eventful year for Trellus, with the launch of the platform and first (modest)revenues generated. Y/E cash of $19.1m was around $2.0m better than our expectations and gives Trellus a cash runway into 2025. The company is now embarking on commercialisation, with the first B2B2C contracts signed and paying subscribers onboarded to the platform. Building a body of RWE is critical to future business development activities around rolling the platform out at scale and active discussions con

Companies: Trellus Health PLC

Singer Capital Markets

19 Oct 22

Trellus IBD now available via GI OnDEMAND

Trellus has announced its IBD solution has been made available on GI OnDEMAND, the leading multidisciplinary care platform for patients with GI conditions. The Trellus solution will now be actively marketed to over 16,000 GI physicians across the US, and in turn to the millions of patients they support. It is a key plank of management’s strategy to open up the D2C channel and, whilst there are no guarantees, it should be supportive to growth from FY23 onwards. In turn, the Real World Evidence ge

Companies: Trellus Health PLC

Singer Capital Markets

17 Oct 22

Two B2B2C contracts signed with Mount Sinai

Trellus has signed two contracts with the Mount Sinai Health System to make its IBD solution available to Mount Sinai employees and members of a large NY state labour union via funded wellness programmes. These contracts were referred to in the recent Interims results and support the company’s strategy of opening access to patients to expand the roll out of its solution. This is a positive step and illustrative of the renewed momentum under the new management team. We look forward to further upd

Companies: Trellus Health PLC

Singer Capital Markets

30 Sep 22

Cash runway extended, multiple near term opps

The incoming new management team at Trellus has acted swiftly to reduce cash burn, extending the runway to early 2025. The company is now transitioning to a revenue-generating business, with the first paying members enrolled post-period end and multiple near term commercial opportunities across its D2C and B2B2C offerings in the advanced stages of finalisation. These should unlock access to substantial patient populations, accelerating adoption of the platform, commercialisation and, ultimately,

Companies: Trellus Health PLC

Singer Capital Markets

13 May 22

Trellus Health (TRLS)

10 May 22

FY21 in line, strategy further refined

FY21 results are in line with expectations, with the business laying the groundwork for market penetration and revenue growth. The D2C model was launched post-period end in Q1-22 and a strong pipeline of pharma co’s and patient advocacy groups are looking to sponsor access to the platform. The B2B contracting process continues to frustrate however, so management has refined its delivery model to enable faster customer acquisition with a more flexible cost base. In conjunction, planned expansion

Companies: Trellus Health PLC

Singer Capital Markets

28 Feb 22

Connecting the whole patient: DTC

Today’s announcement on the launch of the Direct-to-Consumer (DTC) offering in the United States is a further endorsement of continued operational progress. The DTC launch is initially focussed on the states of New York, New Jersey and Connecticut, with plans to further expand in the short term to more than 20 states. This should help accelerate adoption and the generation of real world evidence to support business development activity.

Companies: Trellus Health PLC

Singer Capital Markets

20 Dec 21

Updated roadmap to scale in FY23

Trellus has made strong strategic and operational progress since its IPO in May 2021 and the route to scaled commercialisation is becoming clearer. Commercial launch is now expected in January, with the initial roll-out of the platform for patients with the Mount Sinai employee health plan. Behind this is a pipeline of potential B2B payer contracts, with several in late stage negotiation. The company is also bringing forward its DTC offering which should help accelerate adoption and the generati

Companies: Trellus Health PLC

Singer Capital Markets

16 Sep 21

Hybridan Small Cap Feast 16-09-2021

Joiners No joiners today. Leavers No leavers today. What’s cooking in the IPO kitchen? Peel Hunt, a UK mid and small-cap specialist investment bank, announces its intention to seek admission of its ordinary shares to trading on AIM. Admission is expected to take place on or around 29 September. In conjunction with a placing of Ordinary Shares the Company will be conducting an intermediaries offer. Oxford Nanopore Tech—expected intention to float on the LSE (Standard). The company behind a

Companies: SYM PCIP AAU GLR AFC CRCL VAL KIBO NSCI TRLS

Hybridan

16 Sep 21

Latest partnership opens up multidisciplinary care

The agreement announced today partners Trellus with a licensed multidisciplinary care team employed by Connected Health that has been trained to use Trellus’s proprietary GRITT™ resilience building methodology to deliver first-in-class digital-enabled chronic condition care management services via. the TrellusElevate™ platform. This agreement, like more that are expected to follow, was earmarked in the admission document, and adds the licensed clinical infrastructure to deliver digital-enabled c

Companies: Trellus Health PLC

Singer Capital Markets

23 Aug 21

First demo. contract sets motion for future growth

Today’s announcement marks the signing of Trellus Health’s first demonstration project to use its TrellusElevate™ platform amongst a health plan and is in line with the company strategy outlined at IPO. The agreement with Mount Sinai Health System’s employee health plan aims to initially recruit and engage with 25 Inflammatory Bowel Disease (IBD) patients, to provide a framework for future contract expansions in 2022. The project will produce data on patient recruitment, engagement and programme

Companies: Trellus Health PLC

Singer Capital Markets

01 Jul 21

Connecting the dots - first-to-market health solution

Trellus Health is a provider of a connected health solution for chronic condition management. The TrellusElevate™ platform coordinates and supports the delivery of resilience-driven care using digital tools and a proprietary methodology validated in clinical practice at Mount Sinai. Trellus will initially target the Inflammatory Bowel Disease (IBD) US market (total costs >$45bn pa). The scalability of the opportunity looks compelling, and a pipeline of demo. projects are expected to begin in 202

Companies: Trellus Health PLC

Singer Capital Markets